[Blood coagulation, fibrinolysis and kallikreinogenesis in diabetics with vascular complications treated with insulin or sulfonylurea derivatives].
作者信息
Kaniak J, Kotschy M, Kurzawska M, Paczyńska D
出版信息
Pol Tyg Lek. 1978 Jul 3;33(27):1065-8.
PMID:693380
Abstract
摘要
相似文献
1
2
Proceedings: Half-life of phenprocoumarol (Marcumar R) during treatment with insulin and sulfonylureas in diabetics.
Naunyn Schmiedebergs Arch Pharmacol. 1974;282(Suppl):suppl 282:R30.
3
[Some parameters of hemostasis in diabetic patients].[糖尿病患者止血的一些参数]
Pol Tyg Lek. 1989;44(18-19):420-2.
4
5
[An absence of interaction of sulfametrol-trimethoprim with insulin or sulphonylurea derivatives in diabetics (author's transl)].糖尿病患者中磺胺甲恶唑 - 甲氧苄啶与胰岛素或磺脲类衍生物无相互作用（作者译）
Wien Klin Wochenschr. 1980 Apr 11;92(8):276-9.
6
Letter: Fibrinolytic activity and treatment of diabetes.信件：纤溶活性与糖尿病治疗
Lancet. 1974 Apr 6;1(7858):631-2. doi: 10.1016/s0140-6736(74)92695-6.
7
[Interference of clofibrate in metabolic compensation in dyslipidemic diabetics].[氯贝丁酯对血脂异常糖尿病患者代谢代偿的干扰作用]
Clin Ter. 1979 Oct 15;91(1):57-65.
8
[Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis].
Arzneimittelforschung. 1972 Dec;22:Suppl 12A:2219.
9
[Diamicron].[达美康]
Journ Annu Diabetol Hotel Dieu. 1972;13(0):343-9.
10
[Type distribution of hyperlipoproteinemias in 645 diabetics].[645例糖尿病患者中高脂蛋白血症的类型分布]
Z Gesamte Inn Med. 1977 Jun 1;32(11):suppl 171-4.
Zotero 插件